(Q28194108)

2

0 references

S Brabant

3

0 references

N Sorel

4

0 references

J Allal

5

0 references

G Mauco

6

0 references

A Brizard

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7

0 references

language of work or name

English

0 references

publication date

15 July 2002

0 references

published in

Thrombosis Research

0 references

volume

107

0 references

page(s)

45-9

0 references

issue

1-2

0 references

1 reference

7 January 2021

Effects of acetylsalicylic acid in stroke patients evidence of nonresponders in a subpopulation of treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Aspirin response and failure in cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Development of aspirin resistance in persons with previous ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

PFA-100 system: a new method for assessment of platelet dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Flow cytometry reveals activated GP IIb-IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021

Antithrombotic agents in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900210-4

7 January 2021